title: Treatment of chronic pleural effusion with pleuroperitoneal shunts in dogs: 14 cases (1985-1999).
abstract: OBJECTIVE
  To describe complications and outcome associated with chronic nonseptic pleural effusion treated with pleuroperitoneal shunts in dogs.
  
  
  METHODS
  Retrospective study.
  
  
  METHODS
  14 dogs.
  
  
  METHODS
  Medical records at 4 veterinary schools were examined to identify dogs with chronic nonseptic pleural effusion that were treated by use of a pleuroperitoneal shunt between 1985 and 1999. Signalment, history, physical examination and laboratory findings, cause and type of pleural effusion, medical and surgical treatments, complications, and outcome were reviewed.
  
  
  RESULTS
  10 of 14 dogs had idiopathic chylothorax, and 4 had an identified disease. All but 1 dog with idiopathic chylothorax and 1 dog with chylothorax from a heart base tumor had unsuccessful thoracic duct ligation prior to pump placement. No intraoperative complications developed during shunt placement. Short-term complications developed in 7 of 13 dogs, necessitating shunt removal in 2 dogs and euthanasia in 1. Eight of 11 dogs with long-term follow-up developed complications; the overall mean survival time and the interval in which dogs remained free of clinical signs of pleural effusion were 27 months (range, 1 to 108 months) and 20 months (range, 0.5 to 108 months), respectively.
  
  
  CONCLUSIONS
  Pleuroperitoneal shunts can effectively palliate clinical signs associated with intractable pleural effusion in dogs. Numerous short- and long-term complications related to the shunt should be expected. Most complications can be successfully managed, but even when shunts are functional some treatments fail because of severe abdominal distension or massive pleural fluid production that overwhelms the functional capacity of the shunt.
authors.affiliation: Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus 43210, USA.
authors.forename: D D
authors.initials: DD
authors.lastname: Smeak
authors.lastname: Stephenj
authors.lastname: Birchard
authors.forename: M A
authors.initials: MA
authors.lastname: McLoughlin
authors.forename: M M
authors.initials: MM
authors.lastname: Lindsey
authors.forename: D E
authors.initials: DE
authors.lastname: Holt
authors.forename: D D
authors.initials: DD
authors.lastname: Caywood
authors.forename: M O
authors.initials: MO
authors.lastname: Downs
mesh_terms: D000714:Anastomosis, Surgical / Q000379:methods / Q000662:veterinary; D000818:Animals; D002908:Chronic Disease; D002916:Chylothorax / Q000628:therapy / Q000662:veterinary; D004283:Dog Diseases / Q000601:surgery*; D004285:Dogs; D005260:Female; D008297:Male; D010537:Peritoneum / Q000601:surgery*; D010994:Pleura / Q000601:surgery*; D010996:Pleural Effusion / Q000601:surgery / Q000662:veterinary*; D011183:Postoperative Complications / Q000662:veterinary; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome